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Abstract
Toxoplasma gondii actively invades host cells and establishes a parasitophorous vacuole
(PV) that accumulates many proteins secreted by the dense granules (GRA proteins). To
date, at least 23 GRA proteins have been reported, though the function(s) of most of these
proteins still remains unknown. We targeted gene knockouts at ten GRA gene loci (GRA110) to investigate the cellular roles and essentiality of these classical GRA proteins during
acute infection in the virulent type I RH strain. While eight of these genes (GRA2-9) were
successfully knocked out, targeted knockouts at the GRA1 and GRA10 loci were not
obtained, suggesting these GRA proteins may be essential. As expected, the Δgra2 and
Δgra6 knockouts failed to form an intravacuolar network (IVN). Surprisingly, Δgra7 exhibited
hyper-formation of the IVN in both normal and lipid-free growth conditions. No morphological alterations were identified in parasite or PV structures in the Δgra3, Δgra4, Δgra5,
Δgra8, or Δgra9 knockouts. With the exception of the Δgra3 and Δgra8 knockouts, all of the
GRA knockouts exhibited defects in their infection rate in vitro. While the single GRA knockouts did not exhibit reduced replication rates in vitro, replication rate defects were observed
in three double GRA knockout strains (Δgra4Δgra6, Δgra3Δgra5 and Δgra3Δgra7). However, the virulence of single or double GRA knockout strains in CD1 mice was not affected.
Collectively, our results suggest that while the eight individual GRA proteins investigated in
this study (GRA2-9) are not essential, several GRA proteins may provide redundant and
potentially important functions during acute infection.
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Introduction
Toxoplasma gondii is an obligate intracellular protozoan pathogen capable of infecting any living nucleated cell [1]. As one of the most successful protozoan parasites in the group of cystforming Apicomplexa, Toxoplasma is estimated to chronically infect at least a third of the
world’s population [2]. Infections in immune-competent individuals are typically asymptomatic, though toxoplasmosis can cause severe pathological effects in immune privileged areas
such as the eye or developing fetus [3], and toxoplasmosis is life-threatening in immunocompromised patients [4].
Toxoplasma enters host cells via a rapid active invasion mechanism [5] and utilizes the host
cell plasma membrane to form, within the host cytosol, a distinct compartment termed the
parasitophorous vacuole (PV), in which it replicates and divides [6–8]. Toxoplasma invasion
and PV formation require three Apicomplexa-specific organelles: the micronemes, rhoptries
and dense granules. The secreted microneme proteins (MICs) [9] aid in adhesion to the host
cell and, with the secreted rhoptry neck proteins (RONs) [10], in formation of a moving junction through which the motile parasite penetrates the host cell. The rhoptry organelles also
release rhoptry bulb proteins (ROPs) into the host cell cytosol during invasion. Many ROP proteins re-localize to the non-fusogenic [11] PV membrane (PVM), while other ROP proteins
remain in the host cytoplasm or gain access to the host cell nucleus where they contribute to
reprograming host gene expression [12].
Shortly after the formation of the PV, the dense granule proteins (GRAs) that are defined by
their localization in electron dense granule organelles are massively secreted into the PV lumen
[13–17]. A few proteins secreted by the dense granules exhibit homologies to proteins of
known function such as cathepsin C [18], nucleoside triphosphate hydrolases (NTPases) [19,
20], an osteopontin-like protein [21], protease inhibitors [22, 23] and a lipolytic lecithin:cholesterol acyltransferase [24]. Yet, most GRA proteins do not have any identifiable gene homologues in species other than cyst-forming coccidians. Within the PV lumen, GRA2 initiates the
formation of the membranous tubules that compose the intravacuolar network (IVN) and
GRA6 stabilizes this network [25, 26], which is proposed to provide a scaffold for parasite replication [27, 28]. GRA7 aids in the formation of host organelle sequestering tubular structures
(HOSTs), which are deep PVM invaginations that entrap single shortened host microtubules
to direct host endocytic vacuoles to the PV for nutrient acquisition [29]. GRA7 also interacts
with ROP2 and ROP4 [30] and acts in complex with ROP18 to bind host Immunity-related
GTPase a6 (Irga6) [31], mediating resistance to a major interferon-γ (IFN-γ) triggered macrophage killing mechanism [32]. GRA22 was recently proposed to play a role in parasite egress
[33]. GRA17 and GRA23 were identified as PVM-localized GRAs that mediate passive transport of small molecules [34]. Polymorphic type I GRA6 was recently shown to manipulate the
host cell by activating the host transcription factor nuclear factor of activated T cells 4
(NFAT4) [35]. GRA5 increases the expression of CCR7 [36] and GRA25 induces the expression of CCL2 and C-X-C motif ligand 1 (CXCL1) [37]. Other GRA proteins are exported from
the PV into the host cell cytosol and/or nucleus where they modify host cell signaling pathways
[38]. This exported GRA protein class includes GRA15 [39], GRA16 [40], and GRA24 [41].
Genes encoding several GRA proteins identified in antigen-mapping studies have been previously deleted in virulent type I strains (GRA2, GRA5, GRA6, GRA7, GRA14 and GRA22)
[25, 29, 31, 33, 42–44], or in low-virulence type II strains (GRA3, GRA4 and GRA6) [45, 46].
However, previous gene deletion studies in non-Δku80 strains are complicated by frequent offsite mutation that could influence observed phenotypes [47].
In this study, we utilized the virulent type I Δku80 strain that enables highly efficient and precise development of gene knockouts [46–48] or gene tagging [49] to target gene deletions at the

PLOS ONE | DOI:10.1371/journal.pone.0159306 July 26, 2016

2 / 21

Toxoplasma gondii GRA2-9 Knockout Phenotypes

first ten GRA gene loci (GRA1-10). We isolated 8 of the 10-targeted knockouts (Δgra2-9) and
investigated invasion, growth, morphology and virulence phenotypes. Overall, our findings validate phenotypes associated with several previously reported GRA knockouts, and suggest that
while GRA proteins (GRA2-9) are individually not essential, several of these GRA proteins are
likely to provide redundant and potentially crucial functions during acute infection.

Materials and Methods
Primers
All oligonucleotide primers used in the development of plasmids for targeting gene deletions
(S1 Table) and primers used in the validation of targeted gene deletions (S2 Table) are shown
in the supplementary material. Sequences for primer design and validation of targeting plasmids were obtained from ToxoDB [www.toxodb.org] [50].

Plasmid Construction
Plasmids were developed using yeast recombination cloning that fused a ~1-kb 5’ target flank, a
~2-kb hypoxanthine-xanthine-guanine-phosphoribosyltransferase (HXGPRT) selectable marker
cassette and a ~1-kb 3’ target flank with pRS416 by homologous crossovers at recombination
junctions [48]. DNA elements for yeast recombination were amplified from type I RH (EP;
ATCC 40050) genomic DNA. All targeting plasmids were validated by restriction enzyme digests
and by DNA sequencing. The sequenced and fully annotated type I GT1 strain [www.toxodb.
org] was used to identify GRA gene loci and type I sequences for targeting plasmid assembly.
Plasmid pΔGRA1 was constructed by fusing the HXGPRT minigene cassette between a 1,095-bp
5’ GRA1 genomic target flank and a 940-bp 3’ GRA1 genomic target flank to delete nucleotides
5308191 to 5309090 of the GRA1 locus on chromosome VIII annotated as TGGT1_270250. Plasmid pΔGRA2 was constructed by fusing the HXGPRT minigene cassette between a 1,136-bp 5’
GRA2 genomic target flank and a 1,025-bp 3’ GRA2 genomic target flank to delete nucleotides
814572 to 812564 of the GRA2 locus on chromosome X annotated as TGGT1_227620. Plasmid
pΔGRA2C was constructed by digesting pΔGRA2 with SpeI, followed by self-ligation to remove
the HXGPRT minigene cassette. Plasmid pΔGRA3 was constructed by fusing the HXGPRT minigene cassette between a 950-bp 5’ GRA3 genomic target flank and a 860-bp 3’ GRA3 genomic target flank to delete nucleotides 988787 to 989625 of the GRA3 locus on chromosome X annotated
as TGGT1_227280. Plasmid pΔGRA3C was constructed by digesting pΔGRA3 with SpeI, followed by self-ligation to remove the HXGPRT minigene cassette. Plasmid pΔGRA4 was constructed by fusing the HXGPRT minigene cassette between a 1,130-bp 5’ GRA4 genomic target
flank and a 988-bp 3’ GRA4 genomic target flank to delete nucleotides 1201331 to 1200129 of the
GRA4 locus on chromosome XI annotated as TGGT1_310780. Plasmid pΔGRA4C was constructed by digesting pΔGRA4 with SpeI, followed by self-ligation to remove the HXGPRT minigene cassette. Plasmid pΔGRA5 was constructed by fusing the HXGPRT minigene cassette
between a 1,095-bp 5’ GRA5 genomic target flank and a 956-bp 3’ GRA5 genomic target flank to
delete nucleotides 1753723 to 1754102 of the GRA5 locus on chromosome V annotated as
TGGT1_286450. Plasmid pΔGRA6 was constructed by fusing the HXGPRT minigene cassette
between a 1,057-bp 5’ GRA6 genomic target flank and a 975-bp 3’ GRA6 genomic target flank to
delete nucleotides 7195269 to 7194367 of the GRA6 locus on chromosome X annotated as
TGGT1_275440. Plasmid pΔGRA7 was constructed by fusing the HXGPRT minigene cassette
between a 1,164-bp 5’ GRA7 genomic target flank and a 954-bp 3’ GRA7 genomic target flank to
delete nucleotides 2582896 to 2585701 of the GRA7 locus on chromosome VIIa, annotated as
TGGT1_203310. Plasmid pΔGRA8 was constructed by fusing the HXGPRT minigene cassette
between a 1,151-bp 5’ GRA8 genomic target flank and a 1,015-bp 3’ GRA8 genomic target flank
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to delete nucleotides 1894848 to 1895699 of the GRA8 locus on chromosome III annotated as
TGGT1_354720. Plasmid pΔGRA9 was constructed by fusing the HXGPRT minigene cassette
between a 1,110-bp 5’ GRA9 genomic target flank and a 971-bp 3’ GRA9 genomic target flank
to delete nucleotides 5508787 to 5510441 of the GRA9 locus on chromosome XII annotated as
TGGT1_251540. Plasmid pΔGRA10 was constructed by fusing the HXGPRT minigene cassette
between a 1,170-bp 5’ GRA10 genomic target flank and a 967-bp 3’ GRA10 genomic target flank
to delete nucleotide 6215048 to 6217010 of the GRA10 locus on chromosome VIII annotated as
TGGT1_268900.

Cell and Parasite Cultures
All parasites cultures were maintained in vitro by serial passages in human foreskin fibroblast
(HFF) monolayers (ATCC SCRC-1041.1) in Eagle’s modified essential medium (EMEM) supplemented with 1% fetal bovine serum (FBS) at 36°C [51]. As specified in the text, certain experiments were performed using Dulbelcco’s modified Eagle’s medium (DMEM) supplemented with
10% FBS and 1% sodium pyruvate (D10 medium) or using lipid-free D10 medium (lfD10).

Gene Replacements and Deletions
All strains used or developed in this study are listed in Table 1. Parasites were transformed following previously described methods [47]. Gene replacements using the HXGPRT marker were
selected in 25 μg/mL mycophenolic acid (MPA) and 50 μg/mL xanthine (MPA+X). HXGPRT deletion was selected using 200 μg/mL 6-thioxanthine (6TX). Genotype verification of precisely targeted
gene replacement and deletion events was performed by PCR as previously described [47, 48].

Western Blots
Parasites were isolated from freshly lysed cultures and resuspended in Laemmli buffer. Proteins
were separated by 13% SDS-PAGE (non-reduced conditions), transferred to nitrocellulose
membranes and detected using the following primary antibodies: mAb TG17.179 anti-GRA2
Table 1. Strains used or developed in this study.
Strain

Parent Strain

Genotype

RHΔku80Δhxgprt [48]

RHΔku80::HXGPRT [48]

Δku80Δhxgprt

RHΔku80Δgra2::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra2::HXGPRT

RHΔku80Δgra3::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra3::HXGPRT

RHΔku80Δgra4::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra4::HXGPRT
Δku80Δgra5::HXGPRT

RHΔku80Δgra5::HXGPRT

RHΔku80Δhxgprt

RHΔku80Δgra6::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra6::HXGPRT

RHΔku80Δgra7::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra7::HXGPRT

RHΔku80Δgra8::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra8::HXGPRT

RHΔku80Δgra9::HXGPRT

RHΔku80Δhxgprt

Δku80Δgra9::HXGPRT

RHΔku80Δgra2Δhxgprt

RHΔku80Δgra2::HXGPRT

Δku80Δgra2Δhxgprt

RHΔku80Δgra3Δhxgprt

RHΔku80Δgra3::HXGPRT

Δku80Δgra3Δhxgprt

RHΔku80Δgra4Δhxgprt

RHΔku80Δgra4::HXGPRT

Δku80Δgra4Δhxgprt

RHΔku80Δgra2Δgra4::HXGPRT

RHΔku80Δgra2Δhxgprt

Δku80Δgra2Δgra4::HXGPRT

RHΔku80Δgra2Δgra6::HXGPRT

RHΔku80Δgra2Δhxgprt

Δku80Δgra2Δgra6::HXGPRT

RHΔku80Δgra4Δgra6::HXGPRT

RHΔku80Δgra4Δhxgprt

Δku80Δgra4Δgra6::HXGPRT

RHΔku80Δgra3Δgra5::HXGPRT

RHΔku80Δgra3Δhxgprt

Δku80Δgra3Δgra5::HXGPRT

RHΔku80Δgra3Δgra7::HXGPRT

RHΔku80Δgra3Δhxgprt

Δku80Δgra3Δgra7::HXGPRT

doi:10.1371/journal.pone.0159306.t001
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(1:15,000) [16], mAb T6.2H11 anti-GRA3 (1:10,000) [52], rabbit anti-GRA4 (1:10,000) [53],
mAb TG17.113 anti-GRA5 (1:5,000) [16], rabbit anti-GRA6 (1:20,000) [53], mAb BATO 214
anti-GRA7 (1:15,000) [54], mAb 3.2 anti-GRA8 (1:10,000) [55], rabbit anti-GRA9 (1:2,500)
[56], rabbit anti-actin (1:10,000) [57] or mAb TG054 anti-SAG1 (1:15,000) [58] (antibodies
purchased from the Biotem company, Apprieu, France or kindly provided by L. D. Sibley,
Washington University School of Medicine, Saint-Louis, MO; D. Jacobs, Innogenetics-Fujirebio Europe N.V., Ghent, Belgium; G.E. Ward, University of Vermont College of Medicine, Burlington, VT; W. Daübener, Heinrich Heine Universität, Düsseldorf, Germany). Proteins were
detected with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:20,000; Jackson Immunoresearch Laboratories) and the peroxidase activity was visualized by chemiluminescence using the Supersignal ECL system (Pierce Chemical).

Indirect immunofluorescence
Confluent HFFs were grown on glass coverslips and infected overnight with parasites. For
experiments using lipid free medium, HFFs were equilibrated in lfD10 and parasites were
passed three times in lfD10 prior to infection experiments. Infected cells were fixed in 5% formaldehyde, permeabilized with 0.002% saponin and blocked in 5% goat serum-5% FBS (in Phosphate Buffered Saline (PBS)). Cells were then incubated with primary antibodies for 1 hr in 1%
FBS, 0.002% saponin. Primary antibodies used in this study included mAbTG17.179 antiGRA2 (1:500), mAb T6.2H11 anti-GRA3 (1:500), rabbit anti-GRA4 (1:500), rabbit anti-GRA6
(1:500), mAb BATO 214 anti-GRA7 (1:500), mAb 3.2 anti-GRA8 (1:500), rabbit anti-GRA9
(1:500), and mAb TG 05.54 anti-SAG1 (1: 500). Infected cells were washed and incubated for 1
h with the following secondary antibodies: goat anti-mouse IgG (H+L)-Alexa 488 (1:500, Jackson) or goat anti-mouse IgG (H+L) Alexa 594 (1:500, Jackson) or goat anti-rabbit IgG (H+L)
Alexa 488 (1:500, Jackson). Coverslips were then incubated with 5 μg/mL Hoechst 33342 for 10
min to stain nuclei, mounted in Mowiol and observed using a 100X objective on an Axioplan II
microscope (Zeiss). Images were acquired using a Zeiss black and white camera and the Axio
Vision software (release 4.7.1).

Transmission Electron Microscopy (TEM)
Monolayers of HFFs were grown to confluence on Permanox slides, infected for 24 h in D10or in lfD10 medium, rinsed with PBS, fixed for 2 h with glutaraldehyde diluted in 0.2 M NaPO4
pH 7.4 and processed for TEM, as previously described [25]. To allow preservation of the IVN,
the infected cells were flat embedded and sectioned en face.

Intracellular Replication and Infectivity Assays
The intracellular growth rate was determined in HFFs in a 30-hr growth assay. Freshly lysed
parasites were filtered through a Nuclepore filter to remove host cell debris and used to infect
HFFs at a multiplicity of infection (MOI) of ~ 0.1. An hour after infection the monolayer was
washed with PBS and fresh medium was added to the culture. Cultures were prepared in duplicate. At 30 h post-infection the number of parasites/vacuole was scored from 250 PVs per parasite strain to determine the average number of parasites per vacuole in an HFF cell with a
single PV. Samples were represented as the average number of parasite(s) per PV (± SEM).
Replication rates were compared between parental and knockout strains using a Student’s ttest, with significance being represented as a P value <0.05.
For high throughput replication and infectivity assays, HFF cells were plated in 96 well
plates (10,000 cells per well). Cells were grown for 48 h, rinsed with PBS and 40,000 parasites
of each strain (MOI ~1–2) were deposited into the wells (250 μL per well). Plates were spun at
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400 rpm for 1 min, then incubated for 2 h to allow parasite invasion. After 3 washes in PBS,
fresh D10 medium was added to each well and the plates were returned to culture for 24 h. The
infected monolayers were washed with PBS, incubated with 5 μg/mL Hoechst 33342 for 10
min, rinsed, saturated and permeabilized for 15 min with 5% goat serum– 0.1% triton-X100
(PBS-T), and incubated for 45 min with mAb TG17.043 anti-GRA1 (1:500, Biotem) in PBS-T.
After washes, cells were incubated with goat anti-mouse IgG-Alexa 488 (1:500, Jackson),
washed again, and analyzed by high content screening microscopy using an Olympus IX8
inverted microscope equipped with a black and white Orca ER Camera, and a LUCPLLN
20xPH1 objective. Images of the entire surface of each well were analyzed using the ScanR software. The percentage of infected cells, the total number of parasites per PV as well as the percentage of PVs containing 1, 2, 4, 8, 16 parasites was determined for >5,000 PVs per strain.
Statistical analyses were performed using a Student’s t-test, with significance being represented
as a P-value <0.05.

Ethics Statement
All animal experiments were performed in strict accordance with the U.S.A. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Animals experiments were conducted in an AAALAC approved facility. All animal protocols (protocol bzik.dj2) were
approved by the Institutional Animal Care and Use Committee (Dartmouth College: Animal
Welfare Assurance Number #A3259-01). The humane endpoint of weight loss was used to
determine when animals were euthanized ( 17% body weight loss). Animals were monitored
daily until weight loss occurred then animals were monitored at least twice a day. If the
humane endpoint was reached, animals were euthanized using CO2 and additionally by cervical dislocation. All efforts, including providing diet gel recovery to mice with weight loss, were
made to minimize suffering.

Acute infection
Adult female CD1 mice were obtained from Charles River Laboratory and mice were maintained in Techniplast Seal Safe mouse cages on vent racks and provided with enrichment materials at the Dartmouth-Hitchcock Medical Center (Lebanon, NH) mouse facility. Acute
virulence was determined by a single intraperitoneal injection of the indicated numbers of
tachyzoites into groups of four to eight week old female CD-1 mice (17-21g) per experiment.
Studies were done in a blinded manner to minimize subjective bias. No unexpected deaths
occurred during experiments. Survival was monitored for 30 days and the percentage of surviving animals was determined by the number of animals that survived / the total number of animals that were infected x 100. In all experiments, plaque forming units (PFUs) to tachyzoite
ratios were determined at the time of parasite inoculation to verify infectivity of parasite preparations. Survival was analyzed by the Kaplan-Meier method and curves were compared using
the log rank (Mantel-Cox) test in GraphPad Prism.

Results
Targeted deletion of GRA2, GRA3, GRA4, GRA5, GRA6, GRA7, GRA8,
and GRA9 gene loci
To further investigate the role of the first 10 historically identified GRA proteins (GRA1-10),
we precisely targeted knockouts at each of these unique GRA gene loci using the virulent type I
genetic background deficient in nonhomologous end-joining [48]. Gene knockout targeting
plasmids were constructed according to the representative pΔGRA targeting plasmid shown in
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Fig 1A. These targeting plasmids position the HXGPRT selectable marker between the 5’ and 3’
DNA flanks of the GRA gene of interest, thereby replacing the GRA protein coding sequence
with the HXGPRT selectable marker [59].

Fig 1. Construction and validation of the single GRA2-9 knockout strains. A) Strategy for disruption of a GRA gene locus by double
crossover homologous recombination in type I RHΔku80Δhxgprt using a plasmid, pΔGRA, engineered to contain the 5’ and 3’ target
flanks surrounding the HXGPRT selectable marker. Successful recombination events were selected by mycophenolic acid plus
xanthine (MPA+X). This strategy is representative of each of the gene knockout attempts. B) Validation of the Δgra4 targeted gene
deletion by PCR. The control parental strain is positive for PCR 1 (~ 380 bp) and PCR 2 (~ 670 bp) but negative for PCR 3 (~ 1,100 bp)
and PCR4 (~ 1,200 bp). Clones 1–12 exhibit the banding pattern of a targeted Δgra4 gene knockout,. M: DNA size ladder. C) Western
blot validation of the deletion of GRA2-9. Cell lysates from the equivalent of 2 x 107 parasites were loaded per lane, separated on a 13%
SDS-PAGE (non-reduced conditions), probed with primary antibodies (indicated on the side of the gels), then with goat anti-mouse IgG
or goat anti-rabbit IgG, both coupled to peroxidase and visualized by chemiluminescence.
doi:10.1371/journal.pone.0159306.g001
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Following transfection into the RHΔku80Δhxgprt parental strain [48] and MPA+X selection, we isolated knockout strains deleted for GRA2 (Δgra2), GRA3 (Δgra3), GRA4 (Δgra4),
GRA5 (Δgra5), GRA6 (Δgra6), GRA7 (Δgra7), GRA8 (Δgra8), and GRA9 (Δgra9). Knockouts at
the GRA1 and GRA10 loci were not obtained despite repeated transfection-selection attempts.
The genotypes of the Δgra2-9 knockout strains (Table 1) were validated by PCR as shown in
Fig 1B for the Δgra4 strain. The deletion of each GRA protein was also confirmed by western
blot (Fig 1C), and also by indirect immunofluorescence in HFFs infected overnight (Fig 2).

The loss of single GRA genes does not affect the replication rate
GRA proteins have been proposed to facilitate interactions with the host cell and to potentially
mediate nutrient acquisition [60]. We used two different methodologies to investigate whether
GRA2-9 are necessary for parasite growth in vitro. First, we infected HFFs with each of the
knockout strains and monitored the parasite replication rate by directly counting the number
of parasites per PV in 250 PVs at 30 h post-infection by light microscopy. Using this direct
method, we did not observe any significant defect in replication rates determined by scoring
the number of parasites per PV (Table 2).
To extend this analysis and potentially detect subtle growth defects by analyzing a larger
sample size of more than 5,000 PVs, we used a high throughput automated immunofluorescence method to quantify the percentage of PVs containing 1, 2, 4, 8, 16 parasites and determine the average number of parasites per vacuole (replication rate), as well as the number of
infected HFF cells (infection rate). The results confirmed the data shown in Table 2 revealing
there was no significant reduction in the replication rate of single GRA knockout strains (Fig
3A), though the Δgra7 knockout did exhibit a slight increase in the percentage of PVs containing only 1 or 2 parasites. In contrast, a significant decrease in the infection rate was observed
for the Δgra2, Δgra4, Δgra5, Δgra6, Δgra7, and Δgra9 knockout strains (Fig 3B).

Alteration of the intravacuolar network after deletion of GRA2, GRA6 and
GRA7
To test whether the absence of lipids in growth medium would reveal any distinct morphologic
changes in the Δgra2-9 knockout strains, we infected HFFs in normal D10 medium or HFFs
that were pre-equilibrated in lfD10 medium. Each of the GRA knockout strains developed normal appearing PVs in both D10 (Fig 2) and in lfD10 media as assessed by indirect immunofluorescence assays (Fig 4).
Therefore, we assessed the morphology of the parental and GRA knockout strains cultured
in vitro in D10 or lfD10 media by transmission electron microscopy (TEM). In the Δgra2 (Fig
5A) and Δgra6 (data not shown) knockout strains the parasites, their dense granules and PVM
appeared normal; however, no IVN was observed in mature PVs grown in normal D10
medium (Fig 5A and data not shown), confirming previously reported phenotypes [25]. The
absence of IVN in the mature PV of Δgra2 and Δgra6 strains was also observed in lfD10
medium (Fig 5A and data not shown). Interestingly, the Δgra7 knockout exhibited an increase
in the density of membranous tubules and vesicles that form the IVN of parasites grown both
in D10 and lfD10 media (Fig 5A and 5B). No major morphologic changes in the parasites or
their PV were observed in other GRA knockout strains cultured in normal D10 or delipidated
lfD10 conditions (Fig 5 and data not shown).

Targeted double deletions of dense granule genes
We generated several double GRA knockout strains for GRA proteins that were previously
reported to associate or co-localize [61] to assess whether these GRA proteins may provide
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Fig 2. Indirect immunofluorescence assay verifies deletion of GRA proteins. IFA validation of the deletion of GRA2-9. HFFs were infected overnight
with Δgra knockout strains or with the parental strain. Infected cells were fixed, permeabilized with 0.002% saponin and incubated with the appropriate
primary antibodies (see Material and Methods), followed by Alexa 488-coupled goat anti-mouse IgG or goat anti-rabbit IgG secondary antibodies. After
labeling both the host- and parasite nuclei were revealed with Hoechst 33342; coverslips were mounted in Mowiol and observed by epifluorescence. To
distinguish the shape of Δgra mutants’ vacuoles in the absence of fluorescent signal, we chose to artificially increase their exposure time, which may lead
to some artificial background noise. Scales: 5 μm.
doi:10.1371/journal.pone.0159306.g002

redundant functions. The HXGPRT marker present in the disrupted GRA locus was excised
using the pΔGRAc plasmid and selection in 6-thioxanthine to generate the corresponding
ΔgraΔhxgprt strain (Fig 6A), and genotypes were validated by PCR (Fig 6B). The ΔgraΔhxgprt
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Table 2. Intracellular replication rate of single Δgra knockout parasite strains.
Strain

Mean number of parasites per vacuolea (±SEM)

P (compared to the control strain)b
Signiﬁcance

Control strain genotype

RHΔku80::HXGPRT [48]

19.85 ± 0.76

RHΔku80Δgra2::HXGPRT

19.06 ± 1.29

NS

RHΔku80::HXGPRT

RHΔku80Δgra3::HXGPRT

17.12 ± 1.81

NS

RHΔku80::HXGPRT

RHΔku80Δgra4::HXGPRT

18.94 ± 1.63

NS

RHΔku80::HXGPRT

RHΔku80Δgra5::HXGPRT

22.44 ± 0.83

NS

RHΔku80::HXGPRT

RHΔku80Δgra6::HXGPRT

20.82 ± 0.12

NS

RHΔku80::HXGPRT

RHΔku80Δgra7::HXGPRT

23.38 ± 0.34

NS

RHΔku80::HXGPRT

RHΔku80Δgra8::HXGPRT

19.72 ± 2.23

NS

RHΔku80::HXGPRT

RHΔku80Δgra9::HXGPRT

21.60 ± 1.78

NS

RHΔku80::HXGPRT

a
b

The number of parasites per vacuole was scored at 30 h PI in HFF cells containing a single PV.
P value was determined by a Student’s t-test. NS, not signiﬁcant at P  0.05.

doi:10.1371/journal.pone.0159306.t002

knockout strains were then used to generate double GRA knockout strains following the forward strategy illustrated in Fig 1A using MPA + X selection. Five double GRA knockout
mutants were generated: Δgra2Δgra4, Δgra2Δgra6, Δgra4Δgra6, Δgra3Δgra5 and Δgra3Δgra7
(Table 1). Interestingly, despite several attempts, we failed to isolate a Δgra2Δgra4Δgra6 triple
knockout strain even though each of the three corresponding double GRA knockout gene combinations was successfully isolated (Table 1).

Double GRA knockout strains display defects in replication rate
We measured the in vitro replication rates of the double GRA knockout strains via direct
counting of parasites in > 250 PVs 30 h post-infection. The Δgra4Δgra6, Δgra3Δgra5 and
Δgra3Δgra7 knockout strains exhibited mild defects in their in vitro replication rate (Table 3).
No growth replication defects were observed for the Δgra2Δgra4 or Δgra2Δgra6 knockout
strains (Table 3).

Deletion of GRA2-9 does not affect acute infection or virulence in vivo
Previous work identified several GRA proteins (GRA2, GRA6, and GRA7) as playing a role in
type I parasite virulence during acute infection [25, 31, 37, 42]. To examine the virulence of the
Δgra2-9 knockout strains, we infected CD-1 female mice intraperitoneally with 100 tachyzoites
(parental RH strain LD100 = 1 parasite) and monitored their survival. Absence of these individual GRA proteins (Fig 7A and 7B) or multiple GRA proteins (Fig 7C) did not increase or
decrease virulence during acute infection. All mice succumbed to the infection within 8–12
days.

Discussion
The aim of this study was to apply a more systematic and reliable genetic approach using the
virulent type I strain Δku80 genetic background to examine or re-examine phenotypes associated with the absence of the dense granule proteins GRA1-10. Previously, only one of these ten
GRA proteins (GRA7, [31]) was knocked out in a background that eliminates off-target mutations that could influence phenotypes in non-Δku80 strains [47]. Using the virulent type I
Δku80 genetic model that enables efficient and precise targeted deletion [46–48], we successfully generated parasite strains containing single and double deletions of the GRA loci GRA2-9
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Fig 3. Replication and infection rates of single Δgra2-9 gene knockout strains calculated by high throughput microscopy. A)
Replication rate of each of the Δgra2-9 strains compared to that of the parental strain. The percentage of PVs containing 1, 2, 4, 8 or 16
parasites per vacuole was calculated from three coverslips of infected HFFs. The numbers above each bar represent the average number of
parasites per vacuole calculated from the total number obtained the three coverslips. The values are representative of one experiment out of
three, which provided similar results. B) Percentage of HFFs infected by each Δgra2-9 knockout strain versus the parental Δku80 strain. The
infection rate was calculated from the number of PVs observed on three coverslips. Comparisons between the parental strain and each of
the knockout strains were performed using a Student’s t-test and asterisks indicate significant differences. *: p = 0.0128 for Δgra9; **:
p = 0.0099 for Δgra2, 0.0022 for Δgra4, 0.0051 for Δgra7; ***: p = 0.0003 for Δgra5 and 0.0007 for Δgra6. The values are representative of
one experiment out of three, which provided similar results. The total number of PVs observed in A and B are respectively: parental Δku80
strain, 5,757 (left panel) and 5,206 (right panel); Δgra2, 5,200; Δgra3, 5,173; Δgra4, 6,176; Δgra5, 5,845; Δgra6, 6,311; Δgra7, 5,165; Δgra8,
5,177; Δgra9, 5,065.
doi:10.1371/journal.pone.0159306.g003
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Fig 4. PV formation by Δgra2-9 single knockout strains in normal and lipid-free media. HFFs were preequilibrated in lipid-free D10 media (lfD10), then infected overnight with a single Δgra knockout parasite strain
or the Δku80 parental strain. All parasite strains were passaged 3 times in lfD10 medium prior to infecting
HFFs. Infected cells were fixed, permeabilized with 0.002% saponin, incubated with rabbit serum anti-GRA6
(all strains but Δgra6) or with rabbit serum anti-GRA4 (Δgra6) and with mAb anti-SAG1, visualized with goat
anti-rabbit IgG coupled to Alexa 488 and goat anti-mouse IgG coupled to Alexa 594, mounted in Mowiol and
observed by epifluorescence. To distinguish the shape of Δgra mutants’ vacuoles in the absence of
fluorescent signal, we chose to artificially increase their exposure time, which may lead to some background
noise. Scales: 5 μm.
doi:10.1371/journal.pone.0159306.g004
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Fig 5. Visualization of the Δgra2-9 knockout parasites and PV morphology by transmission electron
microscopy. A) HFFs and parasites were cultured in D10 medium (“Normal D10”) or pre-equilibrated in lipidfree D10 medium (“Lipid-free D10”). Host cells were infected overnight with Δgra2-9 knockout or parental
strains, fixed, and then processed for transmission electron microscopy. Scale: 2 μm. B) Magnification of the
posterior end of an intracellular Δgra7 knockout parasite in “Normal D10” and in “Lipid-free D10” showing the
hyper-formation of the IVN. Scales: 2 μm.
doi:10.1371/journal.pone.0159306.g005

(Table 1). This study is the first to report results on knockouts at the GRA3, GRA4, GRA8 and
GRA9 loci, as well as results on the double GRA knockouts Δgra2Δgra4, Δgra4Δgra6, gra3Δgra5
and Δgra3Δgra7 in the virulent type I RH genetic background.
While knockouts were readily isolated at the GRA2-9 loci, we could not isolate a Δgra1 or a
Δgra10 knockout, suggesting the possibility that these GRA genes are required for parasite
growth or survival, though additional experiments would be necessary to validate this conclusion. Previously, RNA-knockdown of GRA10 expression severely inhibited growth of the parasite in vitro [62]. GRA1 encodes a GRA protein that localizes to the PV lumen as a calciumbinding [63], soluble protein [13]. This unique localization and the inability to knockout these
genes in a type I strain suggests that GRA1 and GRA10 may participate in essential growth
functions. The potential essentiality of the GRA1 and GRA10 genes could be further addressed
in the future using either an inducible type I deletion scheme such as Cre-recombinase [64], an
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Fig 6. Strategy for removal of the HXGPRT selectable marker from a GRA gene locus. A) Removal of
the HXGPRT selectable marker from RHΔku80Δgra::HXGPRT. This strategy is representative of each of the
HXGPRT removal attempts. Following transfection with an HXGPRT-excised plasmid, clones lacking
HXGPRT but containing the 5’ and 3’ flanking regions of the original GRA locus were generated by doublecrossover homologous recombination, using 6TX selection. B) Validation of the HXGPRT removal from the
gra4 gene locus. The parental strain exhibits a PCR5 amplicon of ~ 2,300 bp, corresponding to a DNA
fragment that includes the HXGPRT coding sequence. Clones 1–12 exhibit a PCR5 amplicon of ~ 1,100 bp,
which corresponds to the removal of HXGPRT. M: DNA size ladder; C: control parental strain.
doi:10.1371/journal.pone.0159306.g006

inducible type I expression scheme [65], the CRISPR (clustered regularly interspaced short palindromic repeats)/CAS9 technology [66], or alternatively to apply the recently developed type
II Δku80 genetic model [46] which exhibits extremely rare or undetectable off-site targeting in
comparison to type I Δku80 genetic models [47].
Table 3. Intracellular replication rate of double Δgra knockout parasite strains.
Strain

P (compared to the control strain)b

Mean number of parasites per vacuolea (±SEM)

Signiﬁcance
RHΔku80::HXGPRT (48)

Control strain genotype

19.85 ± 0.76

RHΔku80Δgra2Δgra4::HXGPRT

16.89 ± 1.12

NS

RHΔku80::HXGPRT

RHΔku80Δgra2Δgra6::HXGPRT

18.97 ± 0.56

NS

RHΔku80::HXGPRT

RHΔku80Δgra4Δgra6::HXGPRT

15.53 ± 0.68

S

RHΔku80::HXGPRT

RHΔku80Δgra3Δgra5::HXGPRT

14.14 ± 0.75

S

RHΔku80::HXGPRT

RHΔku80Δgra3Δgra7::HXGPRT

14.85 ± 0.60

S

RHΔku80::HXGPRT

a
b

The number of parasites per vacuole was scored at 30 h post-infection in HFF cells containing a single PV.
P value was determined by a Student’s T-test. S, signiﬁcant at P  0.05; NS, not signiﬁcant.

doi:10.1371/journal.pone.0159306.t003
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Fig 7. Virulence of single and double GRA knockout strains in CD1 mice. One hundred tachyzoites of
the parental (Δku80) or knockout (Δgra) strains were injected intraperitoneally (i.p.) into 8 week old female
CD1 mice and survival was followed for 30 days (n = 8 for Δgra3, Δgra4, Δgra7, Δgra9, Δgra3Δgra5 and
Δgra3Δgra7, n = 4 for Δgra2, Δgra5, Δgra6, Δgra8, Δgra2Δgra4, Δgra2Δgra6, and Δgra4Δgra6). A) Survival of
mice infected with parasites containing single GRA knockouts for IVN-localized GRA proteins. B) Survival of
mice infected with parasites containing single GRA knockouts for PVM-localized GRA proteins. C) Survival of
mice infected with parasites containing double GRA knockouts. Significance was determined by a Student’s
t-test comparing the knockout strain with the parental.
doi:10.1371/journal.pone.0159306.g007

Each of the GRA2-9 proteins contains either a transmembrane hydrophobic alpha-helix or
amphipathic alpha-helices [67] that allow for insertion into and localization at the PVM and/
or the IVN membranes. In addition, GRA2 and GRA6 induce formation and maturation of the
IVN [25, 26] GRA7 was previously identified as a GRA protein possessing the ability to tubulate membranes in vitro [29]. We examined the parasite and PV morphologies of single GRA
knockout strains cultured in both normal D10- and lipid free lfD10 media by indirect
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immunofluorescence and TEM. Interestingly, any phenotype observed in the D10 medium was
also present in the delipidated lfD10 medium. For all single GRA knockout strains the parasites,
their dense granules and their PVM appeared normal in D10 as well as in lfD10 medium. Any
morphological differences in the knockouts occurred only in the IVN structures, reinforcing
the importance of certain GRA proteins as key regulators of the formation and maintenance of
the IVN. In corroboration with previous reports [25], the Δgra2 and the Δgra6 knockout strains
lacked an IVN in D10 and in delipidated lfD10 media. In contrast, the Δgra7 knockout strain
exhibited a hyper-formation of the IVN in both D10 and lfD10 media. TEM images of a previously reported Δgra7 knockout strain [31] also suggests the possibility of hyper-formation of
the IVN, although additional studies are necessary to conclusively determine the magnitude
and significance of this phenotype. While GRA2 and GRA6 are associated with the IVN membranes, GRA7 associates with the PVM but not directly with the IVN membranes [68]. GRA7
was previously shown to deform liposomes into tubular membranes [29], as well as interact
with GRA2 and GRA6 [61]. Collectively, these observations suggest that GRA7 may coordinately regulate IVN functions in conjunction with GRA2 and GRA6. The IVN membranes
were also recently implicated in heterophagy since deletion of GRA2 and subsequent loss of
the IVN decreased the rate at which parasites ingest host cytosolic proteins [69]. The complex
relationship of GRA protein functions in the context of PV membrane functions and IVN
membrane functions merits further investigation.
The high throughput growth assay revealed significant defects in the infection rate in the
Δgra2, Δgra4, Δgra5, Δgra6, Δgra7, and Δgra9 knockout strains. However, with the exception of
a slight increase in percentage of Δgra7 parasite vacuoles with only 1 or 2 parasites, we did not
detect any significant replication rate defect in any of the single GRA knockout strains by direct
scoring of PVs or by automated high-throughput microscopy. GRA proteins traffic as soluble
protein complexes with other GRA proteins to the IVN and PVM [61]. Once inserted into the
membranes they can interact with similarly localized GRA [61] and ROP proteins [30, 31].
Therefore, to determine if GRA proteins could play redundant roles, we generated double GRA
knockout strains of GRA proteins reported to reside in GRA complexes or of GRA proteins
which share similar localization: Δgra2Δgra4, Δgra2Δgra6, Δgra4Δgra6, Δgra3Δgra5 and
Δgra3Δgra7. Of these double GRA knockout strains, we found that the Δgra4Δgra6, Δgra3Δgra5
and Δgra3Δgra7 knockouts displayed significant replication defects in vitro, though the corresponding single knockouts did not. These results suggest that certain GRA proteins most likely
serve redundant function(s) during the tachyzoite stage, or potentially function in a similar
pathway.
Though the canonical GRA proteins are heavily expressed during tachyzoite stages [70],
they appear to be dispensable for acute virulence in type I strains. None of the single or double
deletion strains that we tested exhibited any significant defects in virulence following intraperitoneal infection of CD-1 mice. In contrast, several type I GRA knockout strains were previously
reported to exhibit detectable defects in acute virulence: Δgra2 [42], Δgra6 [25, 37], and Δgra7
[31]. In our virulence assays we injected mice with a dose of 100 tachyzoites using the intraperitoneal route. Previously, Mercier et. al injected many mice with 10 parasites to detect a minor
defect in Δgra2 virulence [42]. In addition, the decreased virulence phenotype of type I Δgra6
and Δgra7 mutants was previously observed following the infection of mice at atypical sites
(sub-cutaneously or in the footpad) [31, 37].
Based on their pattern of secretion and their localization at the PVM as well as at the IVN,
the GRA2-9 proteins may play a role in host-pathogen interactions, nutrient acquisition or vacuole integrity. While we could isolate double GRA knockouts of any double combination of
Δgra2, Δgra4, and Δgra6, we could not isolate the triple Δgra knockout—Δgra2Δgra4Δgra6.
Collectively, our results suggest that while GRA2-9 individually provide non-essential

PLOS ONE | DOI:10.1371/journal.pone.0159306 July 26, 2016

16 / 21

Toxoplasma gondii GRA2-9 Knockout Phenotypes

functions for acute infection, some of these GRA proteins in complexes are likely to play
redundant but necessary roles during acute infection. Additional experiments are still necessary to further define these functions.
The GRA2-9 genes characterized in this study may play essential roles during transition to
or growth in other life stages such as the development of tissue cysts that establish chronic
infection. Most of the GRA2-9 proteins are expressed not only at the tachyzoite stage but also
in the encysted bradyzoite stage [71–74]. Furthermore, a significant role for several of these
GRA proteins (GRA3, GRA4, and GRA6) in type II strains has been reported [45, 46]. These
findings suggest that a key role of PVM- and IVN-localized GRAs may be to prepare the PV
for cyst formation or to provide essential functions during the encysted tissue stages [68].
Though the function of a large number of GRA proteins remains elusive, our study 1) has
reported for the first time the GRA3, GRA4, GRA8 and GRA9 knockouts as well as double
knockouts for GRA2-9 in the type I RH background and 2) has determined that GRA2-9 are
not required for acute virulence following intraperitoneal infection of mice. Additionally we
have identified that a subset of GRA proteins, which cooperate in complexes, appear to provide
key functions associated with IVN formation or function.
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